Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

337.52
+24.507.83%
Post-market: 338.701.18+0.35%19:59 EST
Volume:1.06M
Turnover:356.52M
Market Cap:16.11B
PE:366.87
High:339.97
Open:318.73
Low:316.61
Close:313.02
52wk High:379.63
52wk Low:146.20
Shares:47.74M
Float Shares:47.20M
Volume Ratio:0.66
T/O Rate:2.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9200
EPS(LYR):-2.9122
ROE:1.27%
ROA:4.74%
PB:4.99
PE(LYR):-115.90

Loading ...

Movement Alert|Charles River Laboratories Intraday Rise 5.68% in Regular Trading, Jefferies Raises Price Target to $385

Market Focus
·
Yesterday

Charles River Laboratories International, Inc. Just Beat EPS By 244%: Here's What Analysts Think Will Happen Next

Simply Wall St.
·
Yesterday

Analysts Conflicted on These Healthcare Names: Vaxcyte (PCVX), Charles River Labs (CRL) and HCA Healthcare (HCA)

TIPRANKS
·
Yesterday

Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Yesterday

Cryoport Q3 Revenue Beats Estimates on Cell and Gene Therapy Growth, Lifts Fy2026 Guidance

Reuters
·
Yesterday

Solventum Q3 Sales Fall Slightly Less than Expected; Raises FY Adj EPS Outlook

Reuters
·
Yesterday

Charles River Labs is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Nov 05

Jefferies Adjusts Price Target on Charles River Laboratories International to $385 From $340

MT Newswires Live
·
Nov 05

McGraw Hill Q2 Revenue Falls 5.5% as K-12 Declines

Reuters
·
Nov 05

Charles River price target raised to $375 from $330 at Barclays

TIPRANKS
·
Nov 05

Charles River Laboratories International, Inc. : Jefferies Raises Target Price to $385 from $340

THOMSON REUTERS
·
Nov 05

Pacific Biosciences Q3 Revenue Slightly Beats Expectations on SPRQ-Nx Adoption

Reuters
·
Nov 05

Caris Life Sciences' Q3 Revenue Rises on Molecular Profiling Strength

Reuters
·
Nov 05

Movement Alert|Charles River Laboratories Falls 5.09% in Regular Trading, Post-Earnings Expectation Gap Drives Volatility

Market Focus
·
Nov 04

Charles River Laboratories International, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary

Reuters
·
Nov 04

Charles River Exec Says it Expects Q4 Organic Growth to Stay at Mid-Single Digits in Dsa and High-Single Digits in Manufacturing

THOMSON REUTERS
·
Nov 04

Charles River Exec Says Co Does not Expect Pricing Benefit Until at Least H2 2027

THOMSON REUTERS
·
Nov 04

Charles River Exec Says Overtime Goal is to Cover Annual Cost Inflation Through Price Increases - Conf Call

THOMSON REUTERS
·
Nov 04

Movement Alert|Charles River Laboratories Falls 5.07% in Pre-Market Trading, Post-Earnings Expectation Gap Weighs on Shares

Market Focus
·
Nov 04

Charles River Laboratories Shares up 2.5% Premarket After Q3 Results Beat

THOMSON REUTERS
·
Nov 04